Xvivo Perfusion AB: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
XVIVO Perfusion AB Appoints KPMG as New Auditing Company
XVIVO Perfusion AB announced that the Annual General Meeting (AGM) resolved to appoint KPMG as a new auditing company. Mr. Jan Malm has been elected the principal auditor.
Latest Developments for Xvivo Perfusion AB
- Xvivo Perfusion obtains financing from Vinnova for cancer research
- Xvivo Perfusion AB receives market approval from FDA for Steen Solution and XPS
- XVIVO Perfusion AB receives CE mark for XPS
- XVIVO Perfusion AB announces FDA Advisory Panel's decision that XPS with STEEN Solution meets requirements for HDE approval
- Share this
- Digg this